CGON
Price
$26.10
Change
+$0.03 (+0.12%)
Updated
Jun 27, 12:53 PM (EDT)
Capitalization
1.99B
41 days until earnings call
IRON
Price
$54.62
Change
+$0.49 (+0.91%)
Updated
Jun 27, 01:06 PM (EDT)
Capitalization
1.87B
42 days until earnings call
Interact to see
Advertisement

CGON vs IRON

Header iconCGON vs IRON Comparison
Open Charts CGON vs IRONBanner chart's image
CG Oncology
Price$26.10
Change+$0.03 (+0.12%)
Volume$700
Capitalization1.99B
Disc Medicine
Price$54.62
Change+$0.49 (+0.91%)
Volume$400
Capitalization1.87B
CGON vs IRON Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. IRON commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and IRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CGON: $26.07 vs. IRON: $54.13)
Brand notoriety: CGON and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 52% vs. IRON: 61%
Market capitalization -- CGON: $1.99B vs. IRON: $1.87B
CGON [@Biotechnology] is valued at $1.99B. IRON’s [@Biotechnology] market capitalization is $1.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 2 TA indicator(s) are bullish while IRON’s TA Score has 6 bullish TA indicator(s).

  • CGON’s TA Score: 2 bullish, 3 bearish.
  • IRON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IRON is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -0.80% price change this week, while IRON (@Biotechnology) price change was +8.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.94%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.54%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

IRON is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+9.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.99B) has a higher market cap than IRON($1.88B). CGON YTD gains are higher at: -9.100 vs. IRON (-14.621). IRON has higher annual earnings (EBITDA): -114.41M vs. CGON (-134.35M). IRON (695M) and CGON (688M) have equal amount of cash in the bank . CGON has less debt than IRON: CGON (1.04M) vs IRON (30.6M). CGON has higher revenues than IRON: CGON (662K) vs IRON (0).
CGONIRONCGON / IRON
Capitalization1.99B1.88B106%
EBITDA-134.35M-114.41M117%
Gain YTD-9.100-14.62162%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M695M99%
Total Debt1.04M30.6M3%
TECHNICAL ANALYSIS
Technical Analysis
CGONIRON
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNWFX88.660.91
+1.04%
American Funds New World F3
LMISX24.64N/A
N/A
Franklin U.S. Large Cap Equity IS
PPSFX20.71N/A
N/A
Principal Large Cap Value III R3
SPSCX19.00N/A
N/A
Sterling Capital Behav Sm Cp Val Eq Intl
BOSVX16.78N/A
N/A
Bridgeway Omni Small-Cap Value N

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+0.04%
IDYA - CGON
60%
Loosely correlated
+1.27%
SYRE - CGON
58%
Loosely correlated
+3.96%
ACLX - CGON
57%
Loosely correlated
+1.16%
NUVL - CGON
55%
Loosely correlated
+0.05%
KRYS - CGON
54%
Loosely correlated
+0.06%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with KMSTF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.40%
KMSTF - IRON
54%
Loosely correlated
N/A
CGON - IRON
50%
Loosely correlated
+0.04%
IDYA - IRON
49%
Loosely correlated
+1.27%
SYRE - IRON
48%
Loosely correlated
+3.96%
ZYME - IRON
47%
Loosely correlated
-2.68%
More